FDA
- Status: approved
🇺🇸 6-month dual anti-platelet therapy in United States
6-month dual anti-platelet therapy (6-month dual anti-platelet therapy) regulatory status in United States.
Marketing authorisation
6-month dual anti-platelet therapy in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is 6-month dual anti-platelet therapy approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for 6-month dual anti-platelet therapy in United States?
Gangnam Severance Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.